Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
2998
2.030
 Why?
Mutation
21
2022
1280
1.740
 Why?
High-Throughput Nucleotide Sequencing
5
2021
169
1.010
 Why?
Translocation, Genetic
14
2021
240
0.980
 Why?
Whole Body Imaging
1
2025
26
0.960
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
40
0.950
 Why?
Image Processing, Computer-Assisted
1
2025
243
0.860
 Why?
Bone and Bones
1
2025
478
0.730
 Why?
Oncogenes
2
2018
57
0.730
 Why?
Tomography, X-Ray Computed
1
2025
1164
0.650
 Why?
Biliary Tract Neoplasms
1
2018
9
0.590
 Why?
Gene Expression Profiling
14
2022
1025
0.590
 Why?
Cholangiocarcinoma
1
2018
25
0.590
 Why?
Genomics
8
2022
279
0.540
 Why?
Proto-Oncogene Proteins B-raf
3
2022
80
0.520
 Why?
Gene Expression Regulation, Neoplastic
11
2022
833
0.510
 Why?
Prognosis
15
2021
1978
0.420
 Why?
Brain Neoplasms
3
2023
291
0.400
 Why?
Gene Dosage
5
2020
74
0.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1000
0.390
 Why?
Humans
52
2025
50503
0.390
 Why?
Genetic Predisposition to Disease
5
2018
511
0.380
 Why?
Plasma Cells
4
2021
221
0.370
 Why?
Genome, Human
4
2021
109
0.360
 Why?
Evolution, Molecular
2
2021
95
0.350
 Why?
Liver Neoplasms
3
2022
326
0.350
 Why?
DNA Mutational Analysis
7
2020
175
0.340
 Why?
Thalidomide
5
2019
378
0.330
 Why?
DNA Copy Number Variations
4
2021
109
0.320
 Why?
In Situ Hybridization, Fluorescence
11
2023
231
0.320
 Why?
Software
2
2021
276
0.300
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
112
0.300
 Why?
Neoplasm Recurrence, Local
3
2021
629
0.280
 Why?
Aged
16
2025
9741
0.280
 Why?
Chromosome Aberrations
6
2022
280
0.280
 Why?
Carcinoma, Hepatocellular
2
2022
195
0.270
 Why?
Middle Aged
18
2025
12611
0.270
 Why?
Polymorphism, Single Nucleotide
3
2018
475
0.270
 Why?
Male
26
2025
25907
0.270
 Why?
Female
27
2025
27081
0.260
 Why?
Epigenesis, Genetic
4
2018
372
0.250
 Why?
Clonal Evolution
2
2019
56
0.250
 Why?
Chromosomes, Human, Pair 1
2
2019
92
0.250
 Why?
Immunoglobulin Heavy Chains
3
2014
36
0.250
 Why?
Neoplasm Proteins
3
2017
320
0.240
 Why?
Disease Progression
8
2021
829
0.230
 Why?
Gene Regulatory Networks
2
2022
106
0.220
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
23
0.210
 Why?
Polycomb Repressive Complex 2
2
2021
46
0.210
 Why?
Chromosomes, Human, Pair 14
5
2014
66
0.210
 Why?
Central Nervous System Neoplasms
1
2023
63
0.200
 Why?
Exome
4
2017
48
0.200
 Why?
STAT2 Transcription Factor
1
2021
6
0.190
 Why?
STAT1 Transcription Factor
1
2021
26
0.190
 Why?
Hematologic Neoplasms
1
2023
99
0.190
 Why?
Germ-Line Mutation
2
2021
61
0.190
 Why?
Li-Fraumeni Syndrome
1
2021
11
0.190
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Japan
2
2018
27
0.180
 Why?
Gene Frequency
2
2017
97
0.180
 Why?
Aged, 80 and over
9
2021
3226
0.180
 Why?
Ecosystem
1
2021
65
0.170
 Why?
Neoplasms
2
2020
1251
0.170
 Why?
Cell Cycle
1
2021
226
0.170
 Why?
Glioblastoma
1
2021
94
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Leukemia, Plasma Cell
1
2020
32
0.170
 Why?
DNA Methylation
3
2016
550
0.170
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Genes, myc
1
2019
32
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.160
 Why?
Diploidy
2
2017
26
0.160
 Why?
Cell Survival
2
2018
589
0.150
 Why?
Chromosomes, Human, Pair 11
3
2014
49
0.150
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Genes, Tumor Suppressor
2
2021
73
0.150
 Why?
Mutagenesis
1
2018
58
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
12
0.150
 Why?
Adult
13
2021
13577
0.150
 Why?
Transcriptional Elongation Factors
1
2017
17
0.140
 Why?
Chromosomes, Human, Pair 5
1
2017
15
0.140
 Why?
Histone-Lysine N-Methyltransferase
2
2016
54
0.140
 Why?
Transcriptome
4
2021
313
0.140
 Why?
Enhancer Elements, Genetic
1
2017
58
0.140
 Why?
Reproducibility of Results
1
2021
1197
0.140
 Why?
Chromosomes, Human
1
2017
39
0.140
 Why?
Melanoma
1
2020
280
0.140
 Why?
Hepatocytes
1
2018
178
0.140
 Why?
Immunologic Factors
1
2017
111
0.130
 Why?
B-Lymphocytes
2
2016
171
0.130
 Why?
Neoplasms, Multiple Primary
1
2016
42
0.130
 Why?
Neoplasm Metastasis
1
2016
232
0.130
 Why?
Melphalan
2
2013
178
0.120
 Why?
Oligodendroglioma
1
2015
7
0.120
 Why?
Sequence Analysis, DNA
2
2016
226
0.120
 Why?
Endoribonucleases
1
2015
15
0.120
 Why?
ras Proteins
1
2015
64
0.120
 Why?
Skin Neoplasms
1
2020
491
0.120
 Why?
Survival Rate
4
2020
909
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
40
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
40
0.120
 Why?
Survival Analysis
5
2015
661
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.120
 Why?
Signal Transduction
5
2022
1624
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.110
 Why?
Mutation Rate
3
2021
35
0.110
 Why?
Chromosome Deletion
2
2011
134
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Transcription Factors
2
2015
565
0.110
 Why?
Kaplan-Meier Estimate
4
2018
464
0.110
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
RNA, Neoplasm
1
2013
43
0.110
 Why?
Cell Line, Tumor
4
2022
1398
0.110
 Why?
Nerve Tissue Proteins
1
2015
194
0.110
 Why?
Chromosome Breakage
1
2013
14
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.110
 Why?
Repressor Proteins
1
2014
148
0.100
 Why?
Germinal Center
1
2013
26
0.100
 Why?
Retrospective Studies
1
2025
6263
0.100
 Why?
RNA Splicing
3
2021
38
0.100
 Why?
Genetic Heterogeneity
1
2012
17
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
181
0.100
 Why?
DNA-Binding Proteins
1
2015
418
0.100
 Why?
Acetyltransferases
1
2011
19
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.100
 Why?
RNA, Messenger
1
2015
1089
0.100
 Why?
Antineoplastic Agents
3
2018
1172
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
34
0.090
 Why?
Cell Proliferation
3
2022
985
0.090
 Why?
DNA, Neoplasm
3
2018
143
0.090
 Why?
Multivariate Analysis
3
2021
583
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
78
0.090
 Why?
Phenotype
3
2022
739
0.080
 Why?
Remission Induction
2
2021
208
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
213
0.080
 Why?
Clone Cells
2
2021
70
0.080
 Why?
MicroRNAs
1
2013
344
0.080
 Why?
DNA
1
2012
535
0.080
 Why?
Alleles
2
2021
256
0.080
 Why?
Transcriptional Activation
2
2021
119
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Follow-Up Studies
3
2020
2242
0.070
 Why?
Genomic Instability
2
2018
90
0.070
 Why?
Epigenomics
2
2017
68
0.070
 Why?
Risk Factors
3
2021
3724
0.070
 Why?
Loss of Heterozygosity
2
2018
75
0.060
 Why?
Disease-Free Survival
2
2019
444
0.060
 Why?
Treatment Outcome
4
2019
5283
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
654
0.060
 Why?
Genotype
2
2017
533
0.050
 Why?
Liver
2
2022
1132
0.050
 Why?
Histones
2
2016
297
0.050
 Why?
Dexamethasone
2
2019
432
0.050
 Why?
Proportional Hazards Models
2
2015
415
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
22
0.050
 Why?
Gene Rearrangement
1
2022
65
0.050
 Why?
Nitriles
1
2021
52
0.050
 Why?
Organoids
1
2021
36
0.050
 Why?
Microarray Analysis
2
2012
70
0.050
 Why?
Syndecan-1
1
2021
75
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Chromosome Mapping
2
2011
153
0.050
 Why?
Polymerase Chain Reaction
2
2013
449
0.050
 Why?
Cell Line
2
2015
988
0.040
 Why?
Cell Movement
1
2022
247
0.040
 Why?
Pyrazoles
1
2021
111
0.040
 Why?
Alternative Splicing
1
2021
53
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
 Why?
Pyrimidines
1
2021
191
0.040
 Why?
Phosphoproteins
1
2021
115
0.040
 Why?
Gene Expression
2
2013
610
0.040
 Why?
Lymphoma, Follicular
1
2020
21
0.040
 Why?
Prospective Studies
2
2016
2378
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
659
0.040
 Why?
Young Adult
2
2021
4102
0.040
 Why?
Maintenance Chemotherapy
1
2019
48
0.040
 Why?
Syndrome
1
2019
240
0.040
 Why?
Transcription Elongation, Genetic
1
2017
2
0.040
 Why?
Physical Chromosome Mapping
1
2017
8
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
105
0.040
 Why?
Caspases
1
2018
103
0.040
 Why?
Genetic Loci
1
2017
45
0.040
 Why?
Unfolded Protein Response
1
2017
32
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
212
0.040
 Why?
Mitosis
1
2017
88
0.030
 Why?
Molecular Targeted Therapy
1
2018
123
0.030
 Why?
Genetic Association Studies
1
2017
119
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Algorithms
1
2020
625
0.030
 Why?
Comparative Genomic Hybridization
1
2016
43
0.030
 Why?
Risk
1
2017
324
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
40
0.030
 Why?
Computational Biology
1
2018
215
0.030
 Why?
Nuclear Proteins
1
2017
238
0.030
 Why?
Immunosuppressive Agents
1
2017
225
0.030
 Why?
Tumor Microenvironment
1
2017
222
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
462
0.030
 Why?
RNA Stability
1
2015
23
0.030
 Why?
Patient Selection
1
2016
259
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Amino Acid Sequence
1
2016
574
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
19
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
11
0.030
 Why?
Cytogenetic Analysis
1
2014
74
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
474
0.030
 Why?
Time Factors
1
2021
2935
0.030
 Why?
Introns
1
2014
48
0.030
 Why?
Single-Cell Analysis
1
2014
63
0.030
 Why?
Methylation
1
2014
118
0.030
 Why?
Protein Isoforms
1
2014
116
0.030
 Why?
Down-Regulation
1
2015
340
0.030
 Why?
Base Sequence
1
2015
639
0.030
 Why?
High-Throughput Screening Assays
1
2013
35
0.030
 Why?
Protein Structure, Tertiary
1
2014
245
0.030
 Why?
Molecular Sequence Data
1
2015
778
0.030
 Why?
HeLa Cells
1
2014
247
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
65
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Transforming Growth Factor beta1
1
2013
60
0.030
 Why?
Mass Spectrometry
1
2014
285
0.030
 Why?
Early Detection of Cancer
1
2014
163
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Disease Models, Animal
1
2018
1436
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Tumor Suppressor Proteins
1
2013
128
0.030
 Why?
Apoptosis
1
2018
1097
0.020
 Why?
Gene Library
1
2012
41
0.020
 Why?
Laboratories
1
2012
19
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
930
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
316
0.020
 Why?
Animals
2
2018
13124
0.020
 Why?
Bone Marrow
1
2013
363
0.020
 Why?
Breast Neoplasms
1
2020
1201
0.020
 Why?
Vincristine
1
2010
82
0.020
 Why?
Prednisolone
1
2010
53
0.020
 Why?
Adolescent
1
2021
6443
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
405
0.020
 Why?
Cluster Analysis
1
2010
219
0.020
 Why?
Precancerous Conditions
1
2010
82
0.020
 Why?
Cyclophosphamide
1
2010
168
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
135
0.020
 Why?
Clinical Trials as Topic
1
2012
486
0.020
 Why?
Stem Cell Transplantation
1
2010
179
0.020
 Why?
Child
1
2021
6906
0.020
 Why?
Models, Biological
1
2012
716
0.020
 Why?
Doxorubicin
1
2010
236
0.020
 Why?
Sex Factors
1
2011
712
0.020
 Why?
Up-Regulation
1
2010
446
0.020
 Why?
Risk Assessment
1
2013
1270
0.020
 Why?
Prevalence
1
2011
971
0.020
 Why?
Mice
1
2018
5687
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (266) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department